Cellectis bioresearch, a provider in genome customization and subsidiary of Cellectis, has launched TALEN Access, the first fee-for-service custom TALEN.
Recognized as a pioneer in the development of research products for genome customization, Cellectis bioresearch brings the life sciences community a new tool for specifically modifying genes in any type of cell.
The service will start with the TALEN Access offer, which provides a pair of TALENs for €/$5,000, delivered in less than 3 weeks.
Cellectis bioresearch VP of Sales and Marketing Luc Selig said they are keeping their promise to make genome customization affordable for the hundred of thousands academic research labs.
Cellectis bioresearch was incorporated as a subsidiary of Cellectis in June 2008. It provides life science researchers with ready- and easy-to-use tools for genome customization. These tools, based on sequence specific nucleases, enable the engineering of cells with optimized features for drug discovery, protein production and gene functional studies.